Free online lectures: Explore a world of ideas
TUE, MAR 24, 2015
An innovation in the development of antibiotics at the Kim Lewis Lab at Northeastern University is generating global excitement. Dr. Kim Lewis explains how bacterial resistance to our current antibiotics has reached a critical point. He describes the traditional method of developing antibiotics and then the unique method he and his colleagues pioneered that has led to a major breakthrough. The first result is a new antibiotic, teixobactin, which is in the early stages of testing, but is already making headlines around the world.
BIO: Kim Lewis
Kim Lewis is a University Distinguished Professor and the Director of the Antimicrobial Discovery Center at Northeastern University. The focus of his research is on antimicrobial drug tolerance and drug discovery.
Maryn McKenna on Agriculture, Antibiotics and Big Chicken
Ending Epidemics: Will the U.S. Continue to Lead?
Seth Mnookin: The Panic Virus and Childhood Vaccines
Unraveling the Secrets of Viruses